Asgar Rangoonwala Re-elected as RDPAC Chair, Commits to Advancing China's Healthcare Innovation Ecosystem

On November 21, the Research and Development-based Pharmaceutical Association Committee (RDPAC) of the China Association of Enterprises with Foreign Investment announced the leadership list of its new Executive Committee.

Asgar RANGOONWALA, President of Xian Janssen, Re-elected as Chairman of RDPAC

“As a trusted partner of the Chinese government, RDPAC has been committed for 20 years to supporting China in building a high-level open economy, enhancing pharmaceutical innovation capabilities, and improving patient well-being. I am confident in continuing to lead RDPAC and all its member companies to further refine China’s pharmaceutical innovation ecosystem, fulfill our commitment to benefiting more patients in China and worldwide, and contribute to achieving the Healthy China 2030 goals!”

——AsgarRangoonwala

In recent years, driven by favorable policies, China’s pharmaceutical innovation landscape has been rapidly evolving. RDPAC will continue to uphold its mission of fostering industry consensus, further solidifying the foundations for the sustainable development of the pharmaceutical innovation ecosystem, and supporting the government in continuously optimizing the business and policy environments for pharmaceutical innovation.

RDPAC is a non-profit organization composed of 42 multinational pharmaceutical companies with research and development capabilities, affiliated with the China Association of Enterprises with Foreign Investment. Currently, RDPAC member companies have established 49 manufacturing plants and 31 R&D centers in China, with an annual R&D investment of approximately RMB 8 billion. RDPAC continues to provide high-quality, innovative healthcare products and services to patients in China, supports the establishment of a sustainable innovation ecosystem in China, and is committed to becoming an important partner for China in achieving the Healthy China 2030 goals and continuously improving the quality of life for residents and patients.

Responsible Editor: Sanqi

Disclaimer: This article is reposted from Yaozhi.com. The copyright belongs to the original author. The purpose of reposting is to convey more information, which does not represent the views of this platform. If there are any issues regarding the content, copyright, or other matters, please leave a message on our website, and we will remove the content promptly!